BMO Capital Markets downgraded Pfizer to market performance and told customers that the drug maker will have "significant headwind" over the next two years, with slower revenue and weaker multiple expansion.
Bill Ackmans Pershing Square buys Hilton shares
Back to the future: Saudi investor forum, saved by old leg of oil
Mattel reports surprising increase in North America sales, stocks jump
Elections to the Chhattisgarh Assembly in 2018: A call for boycott of Maoists looms over Dantewada
"We will admit all those who are ready to face the TRS"